Key Highlights
● Fiscal first-quarter 2027 results are due after the market close on Nov. 16.
● Fiscal 2026 Revenue was $48.3 million, with platform revenue up 9.8% to $20.8 million.
● Adjusted EBITDA reached a record $5.8 million for fiscal 2026.
● Total annual Recurring Revenue was $22.5 million, up 7.8%.
Research Solutions, Inc (NASDAQ:RSSS) is scheduled to release fiscal first-quarter 2027 results after the market close on Monday, Nov. 16, with a conference call the following morning. The research workflow and AI software company enters the report having recently made its Scite and Article Galaxy products available inside Microsoft (NASDAQ:MSFT) Copilot, a distribution step that could broaden reach within large enterprises. The quarter may offer an early look at whether platform revenue continues to gain share from the company's declining transaction business. The schedule change makes Monday's release the next scheduled checkpoint.
Latest Company Context
The company moved its results date from Nov. 12 to Nov. 16, with the call set for 9:00 a.m. ET on Nov. 17; no reason was given. For fiscal 2026, ended June 30, Research Solutions reported revenue of $48.3 million, down 1.5%, as platform revenue rose 9.8% to $20.8 million and transaction revenue fell 8.7% to $27.5 million. Gross Margin improved to 51.9% from 49.3%, Net Income rose to $2.8 million, or $0.09 per diluted share, and adjusted EBITDA reached a record $5.8 million. Total annual recurring revenue was $22.5 million, up 7.8%, with B2B ARR up 14.1% to $16.2 million and B2C ARR down 5.6% to $6.3 million. AI-related ARR was $0.8 million. Cash stood at $12.6 million at June 30. On Nov. 11, the company also announced a $1 million agreement with a Fortune 500 biopharma company.
Key Business and index Drivers
The business is shifting toward recurring software revenue. Chief Executive Roy W. Olivier said platform revenue grew to 43% of total revenue in fiscal 2026 from 39% a year earlier. Because platform revenue typically carries higher margins than document transactions, that mix shift has supported gross margin expansion even as total revenue slipped. The Nov.
3 Microsoft announcement adds a distribution channel: Scite lets users check whether cited papers support or contrast with claims and feed peer-reviewed evidence into Copilot's Researcher agent, while Article Galaxy shows whether an organisation already has access to a paper, what it would cost and what uses, including generative AI use, are permitted. Both are available in the Microsoft Marketplace. Separately, a collaboration with publisher MDPI announced in October aims to make open access research more discoverable. B2B platform deployments reached 1,276 at fiscal year-end, up 105 during the year.
What Investors Should Watch
The Nov. 16 release and Nov. 17 call are the immediate catalysts. Investors may watch platform revenue growth and its share of the total, B2B and B2C ARR trends, and AI-related ARR, which rose 125% sequentially in the fiscal fourth quarter from a small base. Any early commentary on Demand generated through the Microsoft Copilot integration, while likely too recent to show in first-quarter numbers, could indicate pipeline interest. The rate of decline in transaction revenue and customer counts, which fell to 1,323 in the fourth quarter from 1,338 a year earlier, may show how quickly the legacy business is shrinking. Management did not provide numeric fiscal 2027 guidance in September, so any outlook would be new information. Details of the $1 million biopharma agreement, including revenue timing, may also be discussed.
A Gradual Shift Toward Platform Revenue
Research Solutions is pairing a gradual shift toward platform revenue with new distribution through Microsoft's ecosystem. The fiscal first-quarter report may show whether that mix shift continues at the pace seen in fiscal 2026 and whether AI-related products are becoming a measurable contributor. With a small revenue base, individual contracts and partnerships can move the numbers, so the trend across several quarters may prove more informative than any single report. Cash generation and margin trends may also be weighed alongside revenue mix.






Please wait processing your request...